SG
Saurabh Garg
About Saurabh Garg
Data last updated:
Saurabh Garg is a Managing Director at Q-Line Biotech Limited (since 2010), Director at Syndicate Diagnostics Private Limited (since 2012) and Director at Heidelco Medicore Private Limited (since 2016), and holds 7 more current directorships. The companies operate in Healthcare, Internet and Real Estate and Construction. The 9 current companies with reported revenue have a combined latest revenue of ₹435 Cr; the largest is Q-Line Biotech Limited at ₹322 Cr (FY 2025). Earlier, Saurabh Garg was a Director at Poct Science House Private Limited (2019–2025) and Director at Mediquity Technologies Private Limited (2021–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 10 Nov 2010 | 2010 | ₹322 Cr (FY 2025) | Active | |
| Director | 18 Apr 2012 | 2012 | ₹58.84 Cr (FY 2025) | Active | |
| Director | 10 Feb 2016 | 2013 | ₹51.23 Cr (FY 2024) | Active | |
| Director | 21 Feb 2019 | 2018 | ₹1.76 Cr (FY 2024) | Active | |
| Director | 12 Jan 2018 | 2018 | ₹1.12 Cr (FY 2025) | Active | |
| Director | 01 Oct 2021 | 1988 | ₹8.2 Lakh (FY 2025) | Active | |
| Director | 21 Mar 2018 | 2018 | ₹4.2 Lakh (FY 2024) | Active | |
| Director | 11 Jul 2023 | 2023 | ₹1.4 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Jan 2019 | 2019 | ₹132 Cr (FY 2024) | Active | |
| Director | 22 Jun 2021 | 2021 | ₹2.99 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Saurabh Garg
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Saurabh Garg
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saurabh Garg
Saurabh Garg currently holds 10 directorships: Q-Line Biotech Limited (Managing Director, since 10 Nov 2010, revenue ₹322 Cr (FY 2025)); Syndicate Diagnostics Private Limited (Director, since 18 Apr 2012, revenue ₹58.84 Cr (FY 2025)); Heidelco Medicore Private Limited (Director, since 10 Feb 2016, revenue ₹51.23 Cr (FY 2024)); Sperogenx Biosciences Private Limited (Director, since 21 Feb 2019, revenue ₹1.76 Cr (FY 2024)); Asg Buildtech Private Limited (Director, since 12 Jan 2018, revenue ₹1.12 Cr (FY 2025)); and 5 more.
Saurabh Garg was first appointed on 10 Nov 2010 as Managing Director at Q-Line Biotech Limited. The most recent appointment on record is 07 Dec 2023 at Q-Line Iris Private Limited.
The 9 current companies of Saurabh Garg that report revenue have a combined latest revenue of ₹435 Cr: Q-Line Biotech Limited ₹322 Cr (FY 2025); Syndicate Diagnostics Private Limited ₹58.84 Cr (FY 2025); Heidelco Medicore Private Limited ₹51.23 Cr (FY 2024); Sperogenx Biosciences Private Limited ₹1.76 Cr (FY 2024); Asg Buildtech Private Limited ₹1.12 Cr (FY 2025); and 4 more.
Saurabh Garg held 2 earlier board appointments: Poct Science House Private Limited (Director, 10 Jan 2019 to 31 Dec 2025); Mediquity Technologies Private Limited (Director, 22 Jun 2021 to 30 Dec 2024).
The current boards of Saurabh Garg's companies include Abhay Agrawal (Q-Line Biotech Limited), Abhishek Mishra (Q-Line Biotech Limited), Ajay Kumar Mahanty (Q-Line Biotech Limited), Akhand Pratap Singh (Q-Line Biotech Limited), Amita Garg (Q-Line Biotech Limited), Ayush Garg (Q-Line Biotech Limited), among others.